WallStreetZen

NYSE: ABBV
AbbVie Inc Stock

ABBV Price
$110.52
Fair Value Price
N/A
Market Cap
$195.05B
52 Week Low
$62.55
52 Week High
$113.41
P/E
23.27x
P/B
12.77x
P/S
3.81x
PEG
0.58x
Dividend Yield
4.17%
Revenue
$40.65B
Earnings
$7.38B
Gross Margin
68.7%
Operating Margin
24.83%
Profit Margin
18.2%
Debt to Equity
8.8
Operating Cash Flow
$16B
Beta
0.82
Next Earnings
Feb 3, 2021
Ex-Dividend
Jan 14, 2021
Next Dividend
Feb 16, 2021

Zen Score

High
Medium
Low
54
Industry average

Reasons for this score

ABBV ($110.52) is trading below its intrinsic value of $664.82, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
ABBV is good value based on its earnings relative to its share price (23.27x), compared to the US market average 33.35x)
Valuation
ABBV is good value based on its earnings relative to its share price (23.27x), compared to the US Drug Manufacturers - General industry average (-6.79x)
Valuation

1 of 13

ABBV News

Valuation

ABBV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
23.27x
Industry
-6.79x
Market
33.35x
ABBV is good value based on its earnings relative to its share price (23.27x), compared to the US market average 33.35x)
Valuation
ABBV is good value based on its earnings relative to its share price (23.27x), compared to the US Drug Manufacturers - General industry average (-6.79x)
Valuation

ABBV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
12.77x
Industry
9.18x
Market
54.32x
ABBV is good value based on its book value relative to its share price (12.77x), compared to the US market average (54.32x)
Valuation
ABBV is poor value based on its book value relative to its share price (12.77x), compared to the US Drug Manufacturers - General industry average (9.18x)
Valuation

ABBV price to earnings growth (PEG)

For valuing profitable companies with growth potential
ABBV is good value based on it's Price to Earnings and rate of earnings growth, measured by PEG ratio (0.58x)
Valuation

ABBV's financial health

Profit margin

Revenue
$12.9B
Net Income
$2.3B
Profit Margin
17.9%
ABBV's Earnings (EBIT) of $10.09B are insufficient to safely cover interest payments on company debt ($87.06B)
Financials
ABBV's profit margin has increased (+8.3%) in the last year from (9.9%) to (18.2%)
Financials

Assets to liabilities

Assets
$149.6B
Liabilities
$134.3B
Debt to equity
5.7
ABBV's short-term liabilities ($24.18B) exceed its short-term assets ($23.01B)
Financials
ABBV's long-term liabilities ($110.15B) exceed its short-term assets ($23.01B)
Financials
ABBV's debt relative to shareholder equity (8.8) has decreased or remained constant compared to 5 years ago (10.28)
Financials
ABBV's debt to equity ratio (8.8) is considered high
Financials

Cash flow

Operating
$5.8B
Investing
-$1.1B
Financing
-$2.8B
ABBV's operating cash flow ($16.01B) may not be sufficient to safely service the company's debt ($87.06B)
Financials

AbbVie Stock FAQ

What is AbbVie's quote symbol?

(NYSE: ABBV) AbbVie trades on the NYSE under the ticker symbol ABBV. AbbVie stock quotes can also be displayed as NYSE: ABBV.

How much is AbbVie's stock price per share?

(NYSE: ABBV) AbbVie stock price per share is $110.52 today (as of Jan 15, 2021).

What is the 52 week high and low for AbbVie (NYSE: ABBV)?

(NYSE: ABBV) AbbVie's 52-week high was $113.41, and its 52-week low was $62.55. It is currently -2.55% from its 52-week high and 76.69% from its 52-week low.

What is AbbVie's Market Cap?

(NYSE: ABBV) AbbVie's market cap is $195.05B, as of Jan 19, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

AbbVie's market cap is calculated by multiplying ABBV's current stock price of $110.52 by ABBV's total outstanding shares of 1,764,833,246.

How much is AbbVie stock worth today?

(NYSE: ABBV) AbbVie currently has 1,764,833,246 outstanding shares. With AbbVie stock trading at $110.52 per share, the total value of AbbVie stock (market capitalization) is $195.05B.

AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. If you had invested in AbbVie stock at $35.12, your return over the last 8 years would have been 214.69%, for an annualized return of 15.41%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics